New Zealand markets open in 7 hours 46 minutes

MRNA Jul 2022 220.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.0600-0.0100 (-14.29%)
As of 09:34AM EDT. Market open.
Full screen
Previous close0.0700
Expiry date2022-07-15
Day's range0.0200 - 0.0600
Contract rangeN/A
Open interest385
  • Zacks

    FDA Panel Recommends Modifying COVID Jabs to Target Omicron

    The FDA's VRBPAC committee recommends updated COVID-19 vaccine boosters that target the Omicron variant to improve vaccine effectiveness.

  • Financial Times

    US FDA panel recommends redesigning Covid vaccine to target Omicron variant

    US government advisers have recommended changing the design of Covid-19 vaccines to target the Omicron variant for a booster campaign aimed at blunting an expected surge of infections in the autumn. Scientists on a Food and Drug Administration advisory committee on Tuesday voted 19 to two in favour of incorporating genetic material from the fast-spreading Omicron variant into a new generation of booster jabs. The recommendation, if approved by US authorities, would pave the way for Moderna and Pfizer to switch manufacturing operations over to making vaccines that experts believe will provide better protection against the most widely circulating Covid variants.

  • Zacks

    Moderna (MRNA) Gains As Market Dips: What You Should Know

    In the latest trading session, Moderna (MRNA) closed at $145.36, marking a +0.76% move from the previous day.